Transcorneal electrical stimulation for patients with retinitis pigmentosa: A prospective, randomized, sham-controlled exploratory study

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 7, 2011, Pages 4485-4496

  Schatz, Andreas ^a   Röck, Tobias ^a   Naycheva, Lubka ^a   Willmann, Gabriel ^a   Wilhelm, Barbara ^b   Peters, Tobias ^b   Bartz Schmidt, Karl Ulrich ^a   Zrenner, Eberhart ^a   Messias, André ^a,c   Gekeler, Florian ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

A WAVE; ADULT; ARTICLE; B WAVE; CLINICAL ARTICLE; COLOR DISCRIMINATION; CONTROLLED STUDY; DARK ADAPTATION; ELECTRORETINOGRAPHY; ELECTROSTIMULATION; HEMATOLOGICAL PARAMETERS; HUMAN; INTRAOCULAR FOREIGN BODY; INTRAOCULAR PRESSURE; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINITIS PIGMENTOSA; SINGLE BLIND PROCEDURE; THERAPY EFFECT; TRANSCORNEAL ELECTRICAL STIMULATION; VISUAL ACUITY; VISUAL FIELD; VISUAL SYSTEM FUNCTION; VISUAL THRESHOLD; CLINICAL TRIAL; COLOR VISION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CORNEA; ELECTROSTIMULATION THERAPY; FOLLOW UP; METHODOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

COLOR PERCEPTION; CORNEA; ELECTRIC STIMULATION THERAPY; ELECTRORETINOGRAPHY; FOLLOW-UP STUDIES; HUMANS; PROSPECTIVE STUDIES; RETINITIS PIGMENTOSA; SINGLE-BLIND METHOD; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELDS;

EID: 80052373259     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6932     Document Type: Article

References (31)

1. Dor H. Beiträge zur Electrotherapie der Augenkrankheiten. Graefes Arch Clin Exp Ophthalmol. 1873;19:352.
2. Fujikado T, Morimoto T, Matsushita K, Shimojo H, Okawa Y, Tano Y. Effect of transcorneal electrical stimulation in patients with nonarteritic ischemic optic neuropathy or traumatic optic neuropathy. Jpn J Ophthalmol. 2006;50:266-273.
3. Inomata K, Shinoda K, Ohde H, et al. Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol. 2007;245:1773-1780.
4. Pardue MT, Phillips MJ, Yin H, et al. Possible sources of neuroprotection following subretinal silicon chip implantation in RCS rats. J Neural Eng. 2005;2:S39-S47.
5. Pardue MT, Phillips MJ, Hanzlicek B, Yin H, Chow AY, Ball SL. Neuroprotection of photoreceptors in the RCS rat after implantation of a subretinal implant in the superior or inferior retina. Adv Exp Med Biol. 2006;572:321-326.
6. Ciavatta VT, Kim M, Wong P, et al. Retinal expression of Fgf2 in RCS rats with subretinal microphotodiode array. Invest Ophthalmol Vis Sci. 2009;50:4523-4530.
7. Morimoto T, Fujikado T, Choi JS, et al. Transcorneal electrical stimulation promotes the survival of photoreceptors and preserves retinal function in royal college of surgeons rats. Invest Ophthalmol Vis Sci. 2007;48:4725-4732.
8. Kent TL, Glybina IV, Abrams GW, Iezzi R. Chronic intravitreous infusion of ciliary neurotrophic factor modulates electrical retinal stimulation thresholds in the RCS rat. Invest Ophthalmol Vis Sci. 2008;49:372-379.
9. Schmid H, Herrmann T, Kohler K, Stett A. Neuroprotective effect of transretinal electrical stimulation on neurons in the inner nuclear layer of the degenerated retina. Brain Res Bull. 2009;79:15-25.
10. Morimoto T, Miyoshi T, Matsuda S, Tano Y, Fujikado T, Fukuda Y. Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system. Invest Ophthalmol Vis Sci. 2005;46:2147-2155.
11. Miyake K, Yoshida M, Inoue Y, Hata Y. Neuroprotective effect of transcorneal electrical stimulation on the acute phase of optic nerve injury. Invest Ophthalmol Vis Sci. 2007;48:2356-2361.
12. Tagami Y, Kurimoto T, Miyoshi T, Morimoto T, Sawai H, Mimura O. Axonal regeneration induced by repetitive electrical stimulation of crushed optic nerve in adult rats. Jpn J Ophthalmol. 2009;53: 257-266.
13. Ni YQ, Gan DK, Xu HD, Xu GZ, Da CD. Neuroprotective effect of transcorneal electrical stimulation on light-induced photoreceptor degeneration. Exp Neurol. 2009;219:439-452.
14. Dawson WW, Trick GL, Litzkow CA. Improved electrode for electroretinography. Invest Ophthalmol Vis Sci. 1979;18:988-991.
15. Gekeler F, Messias A, Ottinger M, Bartz-Schmidt KU, Zrenner E. Phosphenes electrically evoked with DTL electrodes: a study in patients with retinitis pigmentosa, glaucoma, and homonymous visual field loss and normal subjects. Invest Ophthalmol Vis Sci. 2006;47:4966-4974.
16. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69-77.
17. Hood DC, Bach M, Brigell M, et al. ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol. 2008;116:1-11.
18. Schiefer U, Pascual JP, Edmunds B, et al. Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies. Invest Ophthalmol Vis Sci. 2009;50:488-494.
19. Farnsworth D. Investigation on corrective training of color blindness. Sightsav Rev. 1947;17:194-200.
20. Lanthony P. The desaturated panel D-15. Doc Ophthalmol. 1978;46:185-189.
21. Bowman KJ. A method for quantitative scoring of the Farnsworth Panel D-15. Acta Ophthalmol (Copenh). 1982;60:907-916.
22. Vingrys AJ, King-Smith PE. A quantitative scoring technique for panel tests of color vision. Invest Ophthalmol Vis Sci. 1988;29: 50-63.
23. Hocking R. Methods and Applications of Linear Models: Regression and the Analysis of Variance. Hoboken, NJ: John Wiley & Sons; 2003.
24. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368:1795-1809.
25. Berson EL, Rosner B, Sandberg MA, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol. 1993;111:761-772.
26. Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A. 2006;103:3896-3901.
27. Ali RR, Sarra GM, Stephens C, et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet. 2000;25:306-310.
28. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
29. Zrenner E, Bartz-Schmidt KU, Benav H, et al. Subretinal electronic chips allow blind patients to read letters and combine them to words. Proc Biol Sci. 2011;278:1489-1497.
30. Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa? Arch Ophthalmol. 2010;128:493-495.
31. Morimoto T, Miyoshi T, Sawai H, Fujikado T. Optimal parameters of transcorneal electrical stimulation (TES) to be neuroprotective of axotomized RGCs in adult rats. Exp Eye Res. 2010;90:285-291.